Summary: Retatrutide is an investigational triple hormone receptor agonist peptide (GLP-1, GIP, and glucagon) developed by Eli Lilly for obesity treatment, currently in Phase 3 trials and not yet approved by the MHRA or EMA
These post-meal spikes are often followed by crashes, leading to a pattern commonly called the glucose rollercoaster, which is associated with fatigue and increased sugar cravings
We attempt to reach out 10 days prior to your supply running out, but in case we cant make contact, we recommend reaching out to order refills, at the very latest, when you do your 3 injection for the month
These factors were collectively termed incretins
Intravital imaging of islet Ca 2+ dynamics reveals enhanced cell connectivity after bariatric surgery in mice